Mirum Pharmaceuticals, Inc.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash and cash equivalents $52.0m $12.0m $142.1m $31.3m $28.0m $286.3m $222.5m $296.7m
Short-term investments $104.7m $89.7m $125.2m $123.7m $0 $57.8m $86.6m
Accounts receivable $0 $3.3m $24.0m $68.0m $78.3m $123.3m
Inventory $0 $1.5m $5.6m $22.3m $22.4m $24.9m
Prepaid expenses and other current assets $12k $2.7m $4.5m $5.3m $8.9m $10.9m $11.8m $18.1m
Total current assets $52.0m $119.4m $236.3m $166.6m $190.2m $387.5m $392.8m $549.7m
Long-term investments $23.3m $0 $5.0m $0 $0 $12.5m $8.1m
Property and equipment, net $0 $1.4m $1.3m $981k $914k $706k $1.1m $1.9m
Intangible assets, net $18.7m $59.0m $252.9m $249.8m $260.9m
Operating lease right-of-use assets $2.4m $1.9m $1.6m $1.4m $1.3m $8.7m $8.7m
Other assets $324k $1.3m $1.8m $1.4m $4.2m $5.4m $12.0m
Restricted cash $0 $425k $1.5m
Accrued expenses and other current liabilities $111.9m $196.2m
Operating lease liabilities, noncurrent $3.3m $2.6m $1.9m $1.3m $617k $8.0m $7.5m
Convertible notes payable, net, noncurrent $0 $306.4m $308.1m $309.8m
Other liabilities $36k $29k $17k $4.5m $3.8m $2.5m $5.0m
Total stockholders’ equity ($17.3m) $130.3m $172.1m $120.2m $142.0m $248.7m $225.6m $314.7m
Total assets $52.0m $146.7m $240.9m $294.7m $352.9m $646.6m $670.8m $842.8m
Total liabilities and stockholders’ equity $52.0m $146.7m $240.9m $294.7m $352.9m $646.6m $670.8m $842.8m
Accounts payable $269k $3.4m $3.2m $9.2m $8.7m $7.4m $14.6m $9.6m
Total current liabilities $2.4m $13.1m $18.5m $42.6m $64.7m $87.1m $126.6m $205.8m
Total liabilities $2.4m $16.4m $68.8m $174.4m $210.9m $398.0m $445.1m $528.1m
Commitments and contingencies $0 $0
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, and no shares issued and outstanding as of December 31, 2025 and 2024 0 0 0 0 0 0 0
Common stock, $0.0001 par value; 200,000,000 shares authorized; 51,896,391 and 48,338,096 shares issued and outstanding as of December 31, 2025 and 2024, respectively 1k 2k 3k 3k 4k 5k 5k 5k
Additional paid-in capital $34k $200.1m $345.2m $377.4m $535.1m $803.3m $870.2m $981.9m
Accumulated deficit ($17.3m) ($69.9m) ($173.2m) ($257.2m) ($392.8m) ($556.2m) ($644.2m) ($667.5m)
Accumulated other comprehensive income (loss) $129k $83k ($35k) ($217k) $1.6m ($373k) $351k